StockData
Emmaus Life Sciences, Inc. logo

Emmaus Life Sciences, Inc. (EMMA) stock

EMMAOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 2/30
$0.05−0.01 (-14.38%)

Close on Oct 19, 2026Market cap $6.03MP/E –Yield –

Emmaus Life Sciences total assets

Total assets on the balance sheet at the end of each period.

Emmaus Life Sciences's total assets was $16.37M at Jun 30, 2026. For fiscal 2025 it was $21.44M, down 9.2% from the year before. Over ten years it grew 32.0% a year on average. The highest annual figure on record is $59.54M in fiscal 2020.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$21.44M-9.2%
FY2024Dec 31, 2024$23.60M-32.9%
FY2023Dec 31, 2023$35.18M-27.1%
FY2022Dec 31, 2022$48.23M-15.0%
FY2021Dec 31, 2021$56.73M-4.7%
FY2020Dec 31, 2020$59.54M+0.1%
FY2019Dec 31, 2019$59.46M+875.3%
FY2017Sep 30, 2017$6.10M+1090.4%
FY2016Sep 30, 2016$512.10K-9.7%
FY2015Sep 30, 2015$567.10K-57.6%
FY2014Sep 30, 2014$1.34M-4.7%
FY2013Sep 30, 2013$1.40M+1019.1%
FY2012Sep 30, 2012$125.30K-66.1%
FY2011Sep 30, 2011$370.00K+55.8%
FY2010Sep 30, 2010$237.50K–

Quarterly total assets

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 30, 2026$16.37M-29.9%
Q1 FY2026CQ1 2026Mar 31, 2026$18.70M-20.8%
Q4 FY2025CQ4 2025Dec 31, 2025$21.44M-21.6%
Q3 FY2025CQ3 2025Sep 30, 2025$20.76M-20.0%
Q2 FY2025CQ2 2025Jun 30, 2025$23.34M-21.0%
Q4 FY2024CQ4 2024Dec 31, 2024$23.60M-32.9%
Q3 FY2024CQ3 2024Sep 30, 2024$27.34M-42.4%
Q2 FY2024CQ2 2024Jun 30, 2024$25.94M-48.4%
Q1 FY2024CQ1 2024Mar 31, 2024$29.54M-39.6%
Q4 FY2023CQ4 2023Dec 31, 2023$35.18M-27.1%
Q3 FY2023CQ3 2023Sep 30, 2023$47.45M+12.4%
Q2 FY2023CQ2 2023Jun 30, 2023$50.29M+9.3%
Q1 FY2023CQ1 2023Mar 31, 2023$48.95M-4.9%
Q4 FY2022CQ4 2022Dec 31, 2022$48.23M-15.0%
Q3 FY2022CQ3 2022Sep 30, 2022$42.20M-29.7%
Q2 FY2022CQ2 2022Jun 30, 2022$45.99M-27.3%
Q1 FY2022CQ1 2022Mar 31, 2022$51.49M-17.2%
Q4 FY2021CQ4 2021Dec 31, 2021$56.73M-4.7%
Q3 FY2021CQ3 2021Sep 30, 2021$60.06M+0.2%
Q2 FY2021CQ2 2021Jun 30, 2021$63.28M+12.5%
Q1 FY2021CQ1 2021Mar 31, 2021$62.22M-5.7%
Q4 FY2020CQ4 2020Dec 31, 2020$59.54M+0.1%
Q3 FY2020CQ3 2020Sep 30, 2020$59.94M-4.6%
Q2 FY2020CQ2 2020Jun 30, 2020$56.25M-21.0%
Q1 FY2020CQ1 2020Mar 31, 2020$65.99M+982.5%
Q4 FY2019CQ4 2019Dec 31, 2019$59.46M+4797.5%
Q3 FY2019CQ3 2018Jun 30, 2019$62.83M+2485.4%
Q2 FY2019CQ2 2018Mar 31, 2019$71.22M+3883.7%
Q4 FY2017CQ3 2017Sep 30, 2017$6.10M+1090.4%
Q3 FY2017CQ2 2017Jun 30, 2017$1.21M+71.9%
Q2 FY2017CQ1 2017Mar 31, 2017$2.43M+268.3%
Q1 FY2017CQ4 2016Dec 31, 2016$1.79M+93.4%
Q4 FY2016CQ3 2016Sep 30, 2016$512.10K-9.7%
Q3 FY2016CQ2 2016Jun 30, 2016$706.40K+158.7%
Q2 FY2016CQ1 2016Mar 31, 2016$659.90K+45.4%
Q1 FY2016CQ4 2015Dec 31, 2015$924.30K+82.3%
Q4 FY2015CQ3 2015Sep 30, 2015$567.10K–
Q3 FY2015CQ2 2015Jun 30, 2015$273.10K–
Q2 FY2015CQ1 2015Mar 31, 2015$453.70K–
Q1 FY2015CQ4 2014Dec 31, 2014$507.10K–

More Emmaus Life Sciences figures

See a number that looks wrong?